- 1016/S0091-6749(99)70348-9. PMID 10482852.
Kyriakidis I,
Vasileiou E,
Karastrati S,
Tragiannidis A, Gom****s N,
Hatzistilianou M (December 2016). "Primary EBV infection...
- doi:10.1002/14356007.a08_301.pub2. ISBN 978-3527306732.
Kyriakidis I,
Tragiannidis A,
Munchen S,
Groll AH (February 2017). "Clinical
hepatotoxicity ****ociated...
- PMID 24073903. S2CID 30557756.
Kyriakidis I,
Vasileiou E,
Karastrati S,
Tragiannidis A, Gom****s N,
Hatzistilianou M (December 2016). "Primary EBV infection...
- 59. PMID 25901938.
Kyriakidis I,
Mantadakis E,
Stiakaki E,
Groll AH,
Tragiannidis A (October 2022). "Infectious
Complications of
Targeted Therapies in...
- the
public domain.
Kyriakidis I,
Mantadakis E,
Stiakaki E,
Groll AH,
Tragiannidis A (October 2022). "Infectious
Complications of
Targeted Therapies in...
- PMID 29885408. S2CID 47010934.
Kyriakidis I,
Vasileiou E,
Karastrati S,
Tragiannidis A, Gom****s N,
Hatzistilianou M (December 2016). "Primary EBV infection...
- Nast.
Retrieved 8
April 2013. Kyriakidis, I; Vasileiou, E; Pana, Z-D;
Tragiannidis, A (2021). "Acinetobacter
baumannii Antibiotic Resistance Mechanisms"...
- 2016.04.010. PMID 27177994.
Kyriakidis I,
Vasileiou E,
Karastrati S,
Tragiannidis A, Gom****s N,
Hatzistilianou M (December 2016). "Primary EBV infection...
- Drug
Administration (FDA).
September 4, 2008.
Retrieved 2009-11-15.
Tragiannidis A,
Kyriakidis I, Zündorf I,
Groll AH (April 2017). "Invasive
fungal infections...
- 59. PMID 25901938.
Kyriakidis I,
Mantadakis E,
Stiakaki E,
Groll AH,
Tragiannidis A (October 2022). "Infectious
Complications of
Targeted Therapies in...
